The clinical impact of substituting multigene assays: Comparative clinical analysis of PAM50-ROR versus 21-gene assay von Markopoulos, C.J., Hochheiser, L., Hornberger, J., Hytopoulos, E., Stoppler, M.C., Gitlin, M.

Volltext

Summary of head-to-head comparisons of patient (pt) risk classifications by the 21-gene recurrence score (RS) assay and other genomic assays for early breast cancer (EBC) von Varga, Z., Sinn, P., McCullough, D., Lau, A., Stöppler, M.C., Baehner, F.L., Chao, C., Seidman, A.

Volltext